Neogen Chemicals Board Approves Up To ₹600 Crore Fundraising Via QIP

Topline Soars, Margin Jumps PAT at Rs 17.1 Cr in Q1 FY27, +66.8% YoY. Revenue at Rs 250 Cr in Q1 FY27, +34.0% YoY. EBITDA at Rs 52.3 Cr, +59.7% YoY. EBITDA margin at 20.9% vs 17.5%. Board approved fund raise up to Rs 600 Cr via QIP; final dividend for FY26 recommended at Rs 1/sh; AGM on Aug 21, 2026; CRISIL downgraded rating to A-/Negative on Jul 17, 2026; CNK & Associates appointed Internal Auditor for FY27; Neogen Morita New Materials board approved increase in borrowing powers to Rs 500 Cr.